Literature DB >> 8423053

HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies.

S Karaki1, A Kariyone, N Kato, K Kano, Y Iwakura, M Takiguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8423053     DOI： 10.1007/bf00216838

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  10 in total

1.  Functional expression of HLA-C blank antigens on human blood lymphocytes.

Authors:  A Kariyone; M Tanabe; T Juji; K Kano; M Takiguchi
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

2.  Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: evolutionary aspects.

Authors:  D Güssow; R S Rein; I Meijer; W de Hoog; G H Seemann; F M Hochstenbach; H L Ploegh
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  The structure and expression of genes encoding serologically undetected HLA-C locus antigens.

Authors:  M Takiguchi; I Nishimura; H Hayashi; S Karakl; A Kariyone; K Kano
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

4.  Allelic variation in HLA-B and HLA-C sequences and the evolution of the HLA-B alleles.

Authors:  H Pohla; W Kuon; P Tabaczewski; C Doerner; E H Weiss
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Nature of polymorphism in HLA-A, -B, and -C molecules.

Authors:  P Parham; C E Lomen; D A Lawlor; J P Ways; N Holmes; H L Coppin; R D Salter; A M Wan; P D Ennis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain.

Authors:  H Hayashi; P D Ennis; H Ariga; R D Salter; P Parham; K Kano; M Takiguchi
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

7.  Self-tolerance to HLA focuses the response of immunized HLA-transgenic mice on production of antibody to precise polymorphic HLA alloantigens.

Authors:  G J Hämmerling; J W Chamberlain; O Dill; S Y Yang; B Dupont; R Khan; R Chua; S M Weissman; U Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  HLA antibody responses in HLA class I transgenic mice.

Authors:  T Tahara; S Y Yang; R Khan; S Abish; G J Hämmerling; U Hämmerling
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Molecular structure of human histocompatibility antigens: the HLA-C series.

Authors:  D Snary; C J Barnstable; W F Bodmer; M J Crumpton
Journal:  Eur J Immunol       Date:  1977-08       Impact factor: 5.532

10.  Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA-CW3).

Authors:  R Sodoyer; M Damotte; T L Delovitch; J Trucy; B R Jordan; T Strachan
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598
  10 in total
  7 in total

1.  Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.

Authors:  Tomohiro Akahoshi; Takayuki Chikata; Yoshiko Tamura; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  Identification of CTL epitopes in hepatitis C virus by a genome-wide computational scanning and a rational design of peptide vaccine.

Authors:  Toshie Mashiba; Keiko Udaka; Yasuko Hirachi; Yoichi Hiasa; Tomoya Miyakawa; Yoko Satta; Tsutomu Osoda; Sayo Kataoka; Michinori Kohara; Morikazu Onji
Journal:  Immunogenetics       Date:  2007-01-16       Impact factor: 2.846

3.  Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.

Authors:  Hayato Murakoshi; Madoka Koyanagi; Takayuki Chikata; Mohammad Arif Rahman; Nozomi Kuse; Keiko Sakai; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

4.  SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.

Authors:  Chihiro Motozono; Mako Toyoda; Jiri Zahradnik; Akatsuki Saito; Hesham Nasser; Toong Seng Tan; Isaac Ngare; Izumi Kimura; Keiya Uriu; Yusuke Kosugi; Yuan Yue; Ryo Shimizu; Jumpei Ito; Shiho Torii; Akiko Yonekawa; Nobuyuki Shimono; Yoji Nagasaki; Rumi Minami; Takashi Toya; Noritaka Sekiya; Takasuke Fukuhara; Yoshiharu Matsuura; Gideon Schreiber; Terumasa Ikeda; So Nakagawa; Takamasa Ueno; Kei Sato
Journal:  Cell Host Microbe       Date:  2021-06-15       Impact factor: 21.023

5.  Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine.

Authors:  Nozomi Kuse; Yu Zhang; Takayuki Chikata; Hung The Nguyen; Shinichi Oka; Hiroyuki Gatanaga; Masafumi Takiguchi
Journal:  Nat Commun       Date:  2022-09-06       Impact factor: 17.694

6.  The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition.

Authors:  Chihiro Motozono; Mako Toyoda; Toong Seng Tan; Hiroshi Hamana; Yoshihiko Goto; Yoshiki Aritsu; Yusuke Miyashita; Hiroyuki Oshiumi; Kimitoshi Nakamura; Seiji Okada; Keiko Udaka; Mizuki Kitamatsu; Hiroyuki Kishi; Takamasa Ueno
Journal:  Nat Commun       Date:  2022-09-21       Impact factor: 17.694

7.  Effective elicitation of human effector CD8+ T Cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1.

Authors:  Yoshinori Sato; Sayaka Nagata; Masafumi Takiguchi
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.